Alexandre Boissonnas

In vivo priming of HIV-specific CTLs determines selective cross-reactive immune responses against poorly immunogenic HIV-natural variants.

Differential requirement of caspases during naive T cell proliferation.

Fractalkine mediates natural killer-dependent antitumor responses in vivo.

Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.

Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency.

Interplay between cell division and cell death during TCR triggering.

Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration.

The dynamics of dendritic cell-T cell interactions in priming and tolerance.

In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy.

In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor.

Single CX3CL1-Ig DNA administration enhances T cell priming in vivo.

[Stepwise strategy adopted by cytotoxic T cells to eliminate solid tumors].

Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses.

Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.

Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses.

Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.

Multiphoton imaging of cytotoxic T lymphocyte-mediated antitumor immune responses.

Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes.

Antigen localization controls T cell-mediated tumor immunity.

Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells.

Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response.

CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network.

CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice.

Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.

In vivo imaging reveals a pioneer wave of monocyte recruitment into mouse skin wounds.